
Jiangsu operating company of Simcere Pharmaceutical Group, the Chinese pharmaceutical company headquartered in Nanjing and listed in Hong Kong under code 2096. Develops, manufactures and markets medicines concentrated in neurology, oncology and autoimmune disease, including the stroke treatment edaravone dexborneol, and runs its own research institutes in China and the United States alongside manufacturing in Jiangsu.
Để lại đánh giá